1. Home
  2. PFSA vs PASG Comparison

PFSA vs PASG Comparison

Compare PFSA & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSA
  • PASG
  • Stock Information
  • Founded
  • PFSA 2009
  • PASG 2017
  • Country
  • PFSA United States
  • PASG United States
  • Employees
  • PFSA N/A
  • PASG N/A
  • Industry
  • PFSA Medical/Dental Instruments
  • PASG Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFSA Health Care
  • PASG Health Care
  • Exchange
  • PFSA Nasdaq
  • PASG Nasdaq
  • Market Cap
  • PFSA 25.1M
  • PASG 20.3M
  • IPO Year
  • PFSA N/A
  • PASG 2020
  • Fundamental
  • Price
  • PFSA $0.29
  • PASG $8.14
  • Analyst Decision
  • PFSA
  • PASG Strong Buy
  • Analyst Count
  • PFSA 0
  • PASG 4
  • Target Price
  • PFSA N/A
  • PASG $59.25
  • AVG Volume (30 Days)
  • PFSA 15.4M
  • PASG 37.0K
  • Earning Date
  • PFSA 08-14-2025
  • PASG 11-12-2025
  • Dividend Yield
  • PFSA N/A
  • PASG N/A
  • EPS Growth
  • PFSA N/A
  • PASG N/A
  • EPS
  • PFSA N/A
  • PASG N/A
  • Revenue
  • PFSA $75,000.00
  • PASG N/A
  • Revenue This Year
  • PFSA N/A
  • PASG N/A
  • Revenue Next Year
  • PFSA N/A
  • PASG N/A
  • P/E Ratio
  • PFSA N/A
  • PASG N/A
  • Revenue Growth
  • PFSA 66.67
  • PASG N/A
  • 52 Week Low
  • PFSA $0.27
  • PASG $5.12
  • 52 Week High
  • PFSA $5.50
  • PASG $26.60
  • Technical
  • Relative Strength Index (RSI)
  • PFSA N/A
  • PASG 64.11
  • Support Level
  • PFSA N/A
  • PASG $7.09
  • Resistance Level
  • PFSA N/A
  • PASG $8.60
  • Average True Range (ATR)
  • PFSA 0.00
  • PASG 0.45
  • MACD
  • PFSA 0.00
  • PASG 0.09
  • Stochastic Oscillator
  • PFSA 0.00
  • PASG 74.20

About PFSA Profusa Inc. Common Stock

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: